PLTR & HIMS: Vastly Different, Yet Their Financials Tell an Interesting Story
Palantir (PLTR) and Hims & Hers Health (HIMS) operate in completely different industries—one in data analytics and AI for government and enterprises, the other in telehealth and consumer wellness. However, comparing their fundamentals reveals interesting insights into growth, profitability, and market positioning.For example:
Revenue Growth: Both companies have seen strong revenue growth, but Palantir’s government contracts provide stability, while Hims relies on a subscription-based DTC (direct-to-consumer) model.
Profitability: Palantir has achieved GAAP profitability, whereas Hims is still working toward it.
Valuation: PLTR trades at a higher multiple due to its AI-driven hype, while HIMS is valued more as a high-growth healthcare play.
$Hims & Hers Health Inc.(HIMS)$
$Palantir Technologies Inc.(PLTR)$
@TigerStars @Tiger_comments @Daily_Discussion @TigerPM @TigerObserver
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Jeff Chew·2025-02-20TOPCurrently will Palantir extend its bull run after plunging last night?LikeReport